$ News

IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates

IGM Biosciences price target lowered to $1 from $2 at Truist

IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release

Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround

IGM Biosciences downgraded to Hold from Buy at Jefferies

IGM Biosciences Shares Drop 68% as Company Halts Key Programs and Cuts Workforce

IGM Biosciences Stock: Bad News With No Turnaround In Sight

IMG Biosciences enacts massive lay-offs after Phase I trial failure

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

IGM’s autoimmune pivot backfires as top drug disappoints in testing

IGM Biosciences: Dizzying Number Of Pivots

IGM Biosciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

IGM Biosciences, Inc. (IGMS) Reports Q3 Loss, Tops Revenue Estimates

IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update

IGM Biosciences (NASDAQ:IGMS) Is In A Good Position To Deliver On Growth Plans

IGM Biosciences to Present at Three Upcoming Investor Conferences

IGM Biosciences price target raised by $3 at RBC Capital, here's why

Analysts’ Top Healthcare Picks: Intuitive Surgical (ISRG), IGM Biosciences (IGMS)

IGM Biosciences Shifts Focus to Autoimmunity, Appoints New CEO